Polymorphisms of Transmembrane Channel-like 1 Gene are Associated with Kawasaki Disease in Korean Population

  • Lim, Tae-Wan (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Kim, Su-Kang (Kohwang Medical Research Institute, School of Medicine, Kyung Hee University) ;
  • Ban, Ju-Yeon (Department of Dental Pharmacology, College of Dentistry, Dankook University) ;
  • Chung, Joo-Ho (Kohwang Medical Research Institute, School of Medicine, Kyung Hee University) ;
  • Song, Jeong-Yoon (East-West Neo Medical Center, School of Medicine, Kyung Hee University) ;
  • Yoon, Kyung-Lim (East-West Neo Medical Center, School of Medicine, Kyung Hee University) ;
  • Park, Sung-Wook (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyung Hee University) ;
  • Kim, Keon-Sik (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyung Hee University) ;
  • Shin, Ok-Young (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyung Hee University)
  • Published : 2009.12.31

Abstract

Kawasaki disease (KD) is believed to be infectious but etiology and the mechanism of development remain elusive. The aim of this study was to investigate the association between transmembrane channel-like 1 (TMC1) gene and KD. One hundred nine KD patients and 424 normal controls were enrolled. Of all KD patients, 34 developed coronary artery lesions (CALs). Eleven single nucleotide polymorphisms (SNPs) within TMC1 gene were selected and SNP genotyping was performed by the direct sequencing. Genotype frequencies were analyzed with the SNPAnalyzer, Helixtree, and SNPStats programs. In the present study, six SNPs (rs7851577, rs10781105, rs2589615, rs1663743, rs1373628, and rs1373626) were significantly associated with the risk of KD. In further haplotype analysis, one haplotype (CGGACCCT) showed a significant association between KD and control groups. These results suggest that TMC1 gene may be a susceptibility gene for KD in Korean population.

Keywords

References

  1. Burns, J. C. Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J 21:993-995 (2002) https://doi.org/10.1097/00006454-200211000-00002
  2. Baer, A. Z. et al. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med 160:686-690 (2006) https://doi.org/10.1001/archpedi.160.7.686
  3. Burns, J. C. et al. Kawasaki disease: A brief history. Pediatrics 106:E27 (2000) https://doi.org/10.1542/peds.106.2.e27
  4. Hibbard, J. U., Fajardo, J. E. & Briller, J. Kawasaki disease with coronary artery sequelae. Obstet Gynecol 109:517-519 (2007) https://doi.org/10.1097/01.AOG.0000228963.21281.b8
  5. McCrindle, B. W. et al. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr 151:244-248, 248 e241 (2007) https://doi.org/10.1016/j.jpeds.2007.03.056
  6. Rozin, L. et al. Kawasaki disease: a review of pathologic features of stage IV disease and two cases of sudden death among asymptotic young adults. Am J Forensic Med Pathol 24:45-50 (2003) https://doi.org/10.1097/00000433-200303000-00009
  7. Tsuda, E. et al. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease. Cardiol Young 15:481-488 (2005) https://doi.org/10.1017/S1047951105001344
  8. Kurima, K., Yang, Y., Sorber, K. & Griffith, A. J. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 82:300-308 (2003) https://doi.org/10.1016/S0888-7543(03)00154-X
  9. Kurima, K. et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 30:277-284 (2002) https://doi.org/10.1038/ng842
  10. Marcotti, W. et al. Tmc1 is necessary for normal functional maturation and survival of inner and outer hair cells in the mouse cochlea. J Physiol 574:677- 698 (2006) https://doi.org/10.1113/jphysiol.2005.095661
  11. Kalay, E. et al. Four novel TMC1 (DFNB7/DFNB11) mutations in Turkish patients with congenital autosomal recessive nonsyndromic hearing loss. Hum Mutat 26:591 (2005) https://doi.org/10.1002/humu.9384
  12. Makishima, T., Kurima, K., Brewer, C. C. & Griffith, A. J. Early onset and rapid progression of dominant nonsyndromic DFNA36 hearing loss. Otol Neurotol 25:714-719 (2004) https://doi.org/10.1097/00129492-200409000-00011
  13. Tlili, A. et al. TMC1 but not TMC2 is responsible for autosomal recessive nonsyndromic hearing impairment in Tunisian families. Audiol Neurootol 13:213-218 (2008) https://doi.org/10.1159/000115430
  14. Cheung, Y. F. et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122:e608-614 (2008) https://doi.org/10.1542/peds.2008-0646
  15. Ikeda, K. et al. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatr Res 63:182-185 (2008) https://doi.org/10.1203/PDR.0b013e31815ef224
  16. Onouchi, Y. et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42 (2008) https://doi.org/10.1038/ng.2007.59
  17. Hsueh, K. C. et al. Association of vascular endothelial growth factor C-634 g polymorphism in Taiwanese children with Kawasaki disease. Pediatr Cardiol 29:292-296 (2008) https://doi.org/10.1007/s00246-007-9049-3
  18. Jin, H. S. et al. The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 61:584-587 (2007) https://doi.org/10.1203/pdr.0b013e3180459fb5
  19. Nishimura, S. et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143:357-362 (2003) https://doi.org/10.1067/S0022-3476(03)00330-5
  20. Newburger, J. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747- 2771 (2004) https://doi.org/10.1161/01.CIR.0000145143.19711.78